pubmed-article:15964345 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15964345 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
pubmed-article:15964345 | lifeskim:mentions | umls-concept:C0376387 | lld:lifeskim |
pubmed-article:15964345 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
pubmed-article:15964345 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:15964345 | pubmed:dateCreated | 2005-6-20 | lld:pubmed |
pubmed-article:15964345 | pubmed:abstractText | From 1992 to 2001 hepatitis C virus (HCV) viremia was studied in 53 renal transplant recipients anti-HCV+ with at least 3 months follow-up posttransplant using a quantitative retrotranscriptase-PCR method. HCV-RNA was detected in 45 (85%): 29 of the 34 recipients treated with azathioprine-based therapy and 15 of 18 treated with mycophenolate mofetil. Immunosuppressive therapy type did not affect HCV replication. Three different patterns of HCV-RNA evolution were detected: 13 (28.8%) patients with high RNA-HCV levels; 21 (46.7%) patients with low levels; and 11 (24.4%) patients with viremia elevation. In 10 (90%) of 11 of the last group, HCV viremia was detected before 15 days posttransplantation, significantly earlier than in the other two groups. Thus, replication during the first 15 days after transplantation leads to a high RNA-HCV viral load. No clinical symptoms were related to HCV. | lld:pubmed |
pubmed-article:15964345 | pubmed:language | eng | lld:pubmed |
pubmed-article:15964345 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15964345 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15964345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15964345 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15964345 | pubmed:month | Jun | lld:pubmed |
pubmed-article:15964345 | pubmed:issn | 0041-1345 | lld:pubmed |
pubmed-article:15964345 | pubmed:author | pubmed-author:GomezEE | lld:pubmed |
pubmed-article:15964345 | pubmed:author | pubmed-author:VillarMM | lld:pubmed |
pubmed-article:15964345 | pubmed:author | pubmed-author:de OñaMM | lld:pubmed |
pubmed-article:15964345 | pubmed:author | pubmed-author:CHIUS JSJ | lld:pubmed |
pubmed-article:15964345 | pubmed:author | pubmed-author:GalarragaM... | lld:pubmed |
pubmed-article:15964345 | pubmed:author | pubmed-author:MelonSS | lld:pubmed |
pubmed-article:15964345 | pubmed:author | pubmed-author:LauresAA | lld:pubmed |
pubmed-article:15964345 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15964345 | pubmed:volume | 37 | lld:pubmed |
pubmed-article:15964345 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15964345 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15964345 | pubmed:pagination | 2083-5 | lld:pubmed |
pubmed-article:15964345 | pubmed:meshHeading | pubmed-meshheading:15964345... | lld:pubmed |
pubmed-article:15964345 | pubmed:meshHeading | pubmed-meshheading:15964345... | lld:pubmed |
pubmed-article:15964345 | pubmed:meshHeading | pubmed-meshheading:15964345... | lld:pubmed |
pubmed-article:15964345 | pubmed:meshHeading | pubmed-meshheading:15964345... | lld:pubmed |
pubmed-article:15964345 | pubmed:meshHeading | pubmed-meshheading:15964345... | lld:pubmed |
pubmed-article:15964345 | pubmed:meshHeading | pubmed-meshheading:15964345... | lld:pubmed |
pubmed-article:15964345 | pubmed:meshHeading | pubmed-meshheading:15964345... | lld:pubmed |
pubmed-article:15964345 | pubmed:meshHeading | pubmed-meshheading:15964345... | lld:pubmed |
pubmed-article:15964345 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15964345 | pubmed:articleTitle | Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients. | lld:pubmed |
pubmed-article:15964345 | pubmed:affiliation | Department of Virology-Microbiology, Hospital Universitaria Central de Asturias, Celestino Villamil, s/n, Oviedo, Asturias 33006, Spain. santiago.melon@sespa.princast.es | lld:pubmed |
pubmed-article:15964345 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15964345 | lld:pubmed |